FDA Adverse Event Malfunction Summary report: N

APTIMA SARS-COV-2 ASSAY

MDR report key: 13050270 · Received December 21, 2021

Report

Report Number
2024800-2021-00025
Event Type
Malfunction
Date Received
December 21, 2021
Date of Event
September 16, 2021
Report Date
December 20, 2021
Manufacturer
HOLOGIC INCORPORATED
Product Code
QJR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HOLOGIC TECHNICAL SUPPORT (TS) REVIEWED THE LOGS AND DETERMINED NO HARDWARE OR REAGENT PREPARATION ISSUES. ALL VALUES ARE WITHIN RANGE. TS RECOMMENDED FOR THE CUSTOMER TO REVIEW THEIR EXTERNAL QUALITY CONTROL (EQC) STORAGE AND HANDLING. NO FURTHER ISSUES WERE REPORTED.

Description of Event or Problem · 0

CUSTOMER CALLED HOLOGIC TECHNICAL SUPPORT (TS) REQUESTING FOR THEIR LOGS (WORKLIST 001374-20210915-42) TO BE REVIEWED AND FOR HOLOGIC TO PROVIDE FEEDBACK ON POSSIBLE CAUSE OF LOWER RLU VALUES. CUSTOMER USED SARSCOV2 ASSAY LOT 297267 ON PANTHER INSTRUMENT SERIAL (B)(4). CUSTOMER NOTED THAT THE VALUES FOR POSITIVE RESULTS WERE RUNNING LOWER THAN USUAL. CONTROLS ARE VALID BUT OTHER VALUES ARE LOWER THAN EXPECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1954688 APTIMA SARS-COV-2 ASSAY REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID QJR HOLOGIC INCORPORATED 297267

Patients

Seq Age Sex Outcome Treatment
1 Unknown